Autopsy report · NCT00639626

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

“PI left the institution”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 9 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 7 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Nationwide Children's Hospital

Sponsor type

University, hospital or other

Conditions

Cystic Fibrosis Related Diabetes

Interventions

insulin detemir [rDNA origin] injection

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Concussion and Post Traumatic Stress in Traumatic Brain Injury
  “PI has left the institution.” (95% match in meaning)
• Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
  “Former PI Left the Institution” (94% match in meaning)
• Dosing of Methadone for Spine Surgery
  “PI left institution.” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.